Is Artelo Biosciences Stock a Good Investment?
Artelo Biosciences Investment Advice | ARTL |
- Examine Artelo Biosciences' financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
- Research Artelo Biosciences' leadership team and their track record. Good management can help Artelo Biosciences navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
- Consider the overall health of the Pharmaceuticals space and any emerging trends that could impact Artelo Biosciences' business and its evolving consumer preferences.
- Compare Artelo Biosciences' performance and market position to its competitors. Analyze how Artelo Biosciences is positioned in terms of product offerings, innovation, and market share.
- Check if Artelo Biosciences pays a dividend and its dividend yield and payout ratio.
- Review what financial analysts are saying about Artelo Biosciences' stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.
It's important to note that investing in Artelo Biosciences stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if Artelo Biosciences is a good investment.
Sell | Buy |
Strong Sell
Market Performance | Insignificant | Details | |
Volatility | Extremely Dangerous | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | High | Details | |
Economic Sensitivity | Moves indifferently to market moves | Details | |
Investor Sentiment | Impartial | Details | |
Analyst Consensus | Not Available | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unavailable | Details |
Examine Artelo Biosciences Stock
Researching Artelo Biosciences' stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). The company has price-to-book (P/B) ratio of 1.17. Some equities with similar Price to Book (P/B) outperform the market in the long run. Artelo Biosciences recorded a loss per share of 3.05. The entity last dividend was issued on the 21st of June 2019. The firm had 1:15 split on the 10th of August 2022.
To determine if Artelo Biosciences is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Artelo Biosciences' research are outlined below:
| Artelo Biosciences has some characteristics of a very speculative penny stock | |
| Artelo Biosciences had very high historical volatility over the last 90 days | |
| Artelo Biosciences has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (9.83 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Artelo Biosciences currently holds about 21.32 M in cash with (8.35 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 7.51, which can makes it an attractive takeover target, given it will continue generating positive cash flow. |
Artelo Biosciences uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Artelo Biosciences. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Artelo Biosciences' previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 29th of March 2024 Upcoming Quarterly Report | View | |
| 9th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 29th of March 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Artelo Biosciences' market capitalization trends
The company currently falls under 'Nano-Cap' category with a current market capitalization of 3.41 M.Basic technical analysis of Artelo Stock
As of the 24th of March, Artelo Biosciences shows the Risk Adjusted Performance of 0.0539, downside deviation of 3.63, and Mean Deviation of 2.44. Artelo Biosciences technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Please confirm Artelo Biosciences variance, value at risk, as well as the relationship between the Value At Risk and skewness to decide if Artelo Biosciences is priced correctly, providing market reflects its regular price of 1.04 per share. Given that Artelo Biosciences is a hitting penny stock territory we recommend to closely look at its total risk alpha.Artelo Biosciences' insider trading activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Artelo Biosciences insiders, such as employees or executives, is commonly permitted as long as it does not rely on Artelo Biosciences' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Artelo Biosciences insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Artelo Biosciences' Outstanding Corporate Bonds
Artelo Biosciences issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Artelo Biosciences uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Artelo bonds can be classified according to their maturity, which is the date when Artelo Biosciences has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Dana 575 percent Corp BondUS235822AB96 | View | |
| Morgan Stanley 3971 Corp BondUS61744YAL20 | View | |
| AerCap Global Aviation Corp BondUS00773HAA59 | View |
Understand Artelo Biosciences' technical and predictive indicators
Using predictive indicators to make investment decisions involves analyzing Artelo Biosciences' various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.
| Risk Adjusted Performance | 0.0539 | |||
| Market Risk Adjusted Performance | (1.05) | |||
| Mean Deviation | 2.44 | |||
| Semi Deviation | 3.2 | |||
| Downside Deviation | 3.63 | |||
| Coefficient Of Variation | 1921.17 | |||
| Standard Deviation | 3.99 | |||
| Variance | 15.92 | |||
| Information Ratio | 0.0664 | |||
| Jensen Alpha | 0.1851 | |||
| Total Risk Alpha | 0.5008 | |||
| Sortino Ratio | 0.073 | |||
| Treynor Ratio | (1.06) | |||
| Maximum Drawdown | 34.05 | |||
| Value At Risk | (3.45) | |||
| Potential Upside | 4.59 | |||
| Downside Variance | 13.19 | |||
| Semi Variance | 10.26 | |||
| Expected Short fall | (3.06) | |||
| Skewness | 1.23 | |||
| Kurtosis | 11.19 |
| Risk Adjusted Performance | 0.0539 | |||
| Market Risk Adjusted Performance | (1.05) | |||
| Mean Deviation | 2.44 | |||
| Semi Deviation | 3.2 | |||
| Downside Deviation | 3.63 | |||
| Coefficient Of Variation | 1921.17 | |||
| Standard Deviation | 3.99 | |||
| Variance | 15.92 | |||
| Information Ratio | 0.0664 | |||
| Jensen Alpha | 0.1851 | |||
| Total Risk Alpha | 0.5008 | |||
| Sortino Ratio | 0.073 | |||
| Treynor Ratio | (1.06) | |||
| Maximum Drawdown | 34.05 | |||
| Value At Risk | (3.45) | |||
| Potential Upside | 4.59 | |||
| Downside Variance | 13.19 | |||
| Semi Variance | 10.26 | |||
| Expected Short fall | (3.06) | |||
| Skewness | 1.23 | |||
| Kurtosis | 11.19 |
Consider Artelo Biosciences' intraday indicators
Artelo Biosciences intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Artelo Biosciences stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Artelo Biosciences time-series forecasting models is one of many Artelo Biosciences' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Artelo Biosciences' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.
Artelo Stock media impact
Far too much social signal, news, headlines, and media speculation about Artelo Biosciences that are available to investors today. That information is available publicly through Artelo media outlets and privately through word of mouth or via Artelo internal channels. However, regardless of the origin, that massive amount of Artelo data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Artelo Biosciences news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Artelo Biosciences relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Artelo Biosciences' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Artelo Biosciences alpha.
Artelo Biosciences Corporate Management
| Jason Baybutt | Senior Finance | Profile | |
| Andrew Yates | Senior Officer | Profile | |
| Steven Reich | Chief Officer | Profile | |
| Steven MD | Chief Officer | Profile | |
| Gregory MBA | CEO and President | Profile |
Already Invested in Artelo Biosciences?
The danger of trading Artelo Biosciences is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Artelo Biosciences is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Artelo Biosciences. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Artelo Biosciences is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Artelo Biosciences is a strong investment it is important to analyze Artelo Biosciences' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Artelo Biosciences' future performance. For an informed investment choice regarding Artelo Stock, refer to the following important reports: Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Artelo Biosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. For more information on how to buy Artelo Stock please use our How to buy in Artelo Stock guide.You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Artelo Biosciences. If investors know Artelo will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Artelo Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Artelo Biosciences is measured differently than its book value, which is the value of Artelo that is recorded on the company's balance sheet. Investors also form their own opinion of Artelo Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Artelo Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Artelo Biosciences' market value can be influenced by many factors that don't directly affect Artelo Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
In summary, please note that there is a difference between Artelo Biosciences' value and its price, as these two are different measures arrived at by various means. Investors typically determine if Artelo Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Artelo Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.